SCHEMBL4854072

SCHEMBL4854072

Cc1cc(C)cc(-c2ccc(OCCN(C)C)c(C=CC(=O)c3ccc(O)cc3F)c2)c1

nearest known ligand 0.42

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
KDR P35968 3/20 0.41
SYK P43405 2/20 0.40
CHRNA7 P36544 1/20 0.39
CAPN1 P07384 1/20 0.36
CTSL P07711 1/20 0.36
NR1H4 Q96RI1 1/20 0.36
MEN1 O00255 2/20 0.36
LMNA P02545 2/20 0.36
HPGD P15428 2/20 0.36
KMT2A Q03164 2/20 0.36
MELK Q14680 1/20 0.36
BACE1 P56817 1/20 0.35
GAA P10253 2/20 0.35
KDM4E B2RXH2 1/20 0.35
ALDH1A1 P00352 1/20 0.35
ALOX12 P18054 1/20 0.35
MAOB P27338 1/20 0.35
TYR P14679 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4853788 0.91 MEN1 (0.40) SYKMEN1LMNAHPGDKMT2A
SCHEMBL4854062 0.90 SYK (0.43) KDRSYKCHRNA7CTSLMELK
SCHEMBL4854543 0.90 SYK (0.43) KDRSYKCHRNA7CTSLMELK
SCHEMBL4846635 0.89 LMNA (0.48) SYKMEN1LMNAHPGDKMT2A
SCHEMBL4849980 0.89 SLC6A9 (0.42) KDRSYKKDM4EALDH1A1MAOB
SCHEMBL4852218 0.85 CAPN1 (0.50) CHRNA7CAPN1CTSLLMNAMAOB
SCHEMBL4846881 0.83 MAOB (0.48) CHRNA7MEN1LMNAKMT2AKDM4E
SCHEMBL4849810 0.83 ABCB1 (0.43) SYKKDM4EALDH1A1MAOB
SCHEMBL4847320 0.83 SNCA (0.44) KDRSYK
SCHEMBL4853514 0.83 NR1H4 (0.47) KDRCHRNA7CAPN1NR1H4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050227990-A1 Aminoalkoxy-functional chalcones LICA PHARMACEUTICALS A/S (DK) 2005-10-13 US claimed
US-7423181-B2 in particular against bacterial and parasitic infections, fungi, and helminths; improved metabolic and physiochemical properties, bioavailability, solubility; 3-[4-(2-Dimethylamino-ethoxy)-2'-trifluoromethyl-biphenyl-3-yl]-1-(2-dimethylaminomethyl-phenyl)-propenone LICA PHARMACEUTICALS A/S (DK) 2008-09-09 US disclosed
US-20050227990-A1 Aminoalkoxy-functional chalcones LICA PHARMACEUTICALS A/S (DK) 2005-10-13 US disclosed